Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Non-cash Items (2016 - 2017)

Ultragenyx Pharmaceutical has reported Non-cash Items over the past 3 years, most recently at $2.7 million for Q4 2017.

  • Quarterly Non-cash Items fell 96.58% to $2.7 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $2.7 million through Dec 2017, down 96.58% year-over-year, with the annual reading at $2.7 million for FY2017, 96.58% down from the prior year.
  • Non-cash Items was $2.7 million for Q4 2017 at Ultragenyx Pharmaceutical, down from $79.1 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $217.4 million in Q4 2015 and troughed at $2.7 million in Q4 2017.
  • The 3-year median for Non-cash Items is $79.1 million (2016), against an average of $99.7 million.
  • Year-over-year, Non-cash Items crashed 63.6% in 2016 and then crashed 96.58% in 2017.
  • A 3-year view of Non-cash Items shows it stood at $217.4 million in 2015, then crashed by 63.6% to $79.1 million in 2016, then crashed by 96.58% to $2.7 million in 2017.
  • Per Business Quant, the three most recent readings for RARE's Non-cash Items are $2.7 million (Q4 2017), $79.1 million (Q4 2016), and $217.4 million (Q4 2015).